Date | Title | Description | Source |
12.03.2024 | Allogene Therapeutics and Arbor Biotechnologies Announce Glo... | - | globenewsw... |
05.03.2024 | Allogene Therapeutics to Report Fourth Quarter and Full Year... | - | globenewsw... |
12.01.2022 | Allogene Therapeutics : JPM Presentation 2022 | The Next Revolution in Cell Therapy
Leading Today, Defining Tomorrow
January 2022
Legal Disclaimers
... | marketscre... |
14.12.2021 | Allogene Therapeutics : ASH 2021 Conference Call Presentatio... | The Potential Innovation of Allogeneic CAR T Therapy in Hematologic Cancers
American Society of Hema... | marketscre... |
15.11.2021 | Allogene Therapeutics : Corporate Presentation - November 20... | The Next Revolution in Cell Therapy
Leading Today, Creating Tomorrow
November 2021
Legal Disclaimers... | marketscre... |
10.08.2021 | Bringing immuno-oncology cell therapies to the masses – are ... | | ucltf.co.u... |
10.02.2021 | Allogene partner Notch snags $85M for renewable cell therapi... | Several companies are working to make cell therapies cheaper and more widely available by making the... | fiercebiot... |
10.02.2021 | Allogene partner Notch snags $85M for renewable cell therapi... | Several companies are working to make cell therapies cheaper and more widely available by making the... | fiercebiot... |
19.01.2021 | ALLOGENE THERAPEUTICS, INC.
Allogene Therapeutics : J.P. Mo... | The Next Revolution in Cell Therapy
Leading Today, Creating Tomorrow
39th Annual J.P. Morgan Healthc... | marketscre... |
19.01.2021 | Allogene Therapeutics : J.P. Morgan Conference Presentation ... | The Next Revolution in Cell Therapy
Leading Today, Creating Tomorrow
39th Annual J.P. Morgan Healthc... | marketscre... |
15.01.2021 | Allogene Therapeutics : J.P. Morgan Conference Presentation ... | The Next Revolution in Cell Therapy
Leading Today, Creating Tomorrow
39th Annual J.P. Morgan Healthc... | marketscre... |
15.01.2021 | ALLOGENE THERAPEUTICS, INC.
Allogene Therapeutics : J.P. Mo... | The Next Revolution in Cell Therapy
Leading Today, Creating Tomorrow
39th Annual J.P. Morgan Healthc... | marketscre... |
13.01.2021 | ALLOGENE THERAPEUTICS, INC.
Allogene Therapeutics : Corpora... | The Next Revolution in Cell Therapy
Leading Today, Creating Tomorrow
January 2021
Legal Disclaimers
... | marketscre... |
12.01.2021 | Allogene Therapeutics : Corporate Presentation January 2021 | The Next Revolution in Cell Therapy
Leading Today, Creating Tomorrow
January 2021
Legal Disclaimers
... | marketscre... |
20.10.2020 | MD Anderson establishes new $50M+ biotech fund to choos... | Researchers at MD Anderson have a new partner to help them get early-stage programs into the ... | endpts.com... |
15.01.2020 | Astellas partners with Adaptimmune in latest move into cell ... | Most TCRs that have been developed are HLA-restricted, meaning they can only be used in patients wit... | medcitynew... |
05.11.2019 | Notch Therapeutics Announces R&D Collaboration with Allo... | SOUTH SAN FRANCISCO, Calif. and TORONTO — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-sta... | lumiravent... |
28.01.2019 | Allogene gets FDA go-ahead to start ‘off-the-shelf’ CAR-T st... | ALLO-501 targets CD19, an antigen widely expressed in B-cell non-Hodgkin’s lymphomas like DLBCL and ... | medcitynew... |
07.12.2018 | Moderna raises more than $600M in biggest-ever biotech IPO | Moderna had raised $500 million in a Series G financing round of private equity financing that gave ... | medcitynew... |
04.12.2018 | Allogene ‘off-the-shelf’ CAR-T for leukemia shows high respo... | Allogene made headlines earlier this year when it launched in April with a $300 million Series A rou... | medcitynew... |
12.11.2018 | Moderna Therapeutics seeks $500M for IPO | The filing comes nine months after the company closed a $500 million Series G round of private equit... | medcitynew... |
09.11.2018 | Big dreams, big pay and a big IPO: Moderna lights up a pit... | Moderna’s executive team never does anything small — or non-controversial.
They’ve built a... | endpts.com... |
04.11.2018 | Life sciences VC investment trends similar to tech, but ther... | There are some similar trends in the life sciences market versus technology overall, but there are s... | medcitynew... |
24.10.2018 | Какие стартапы борются с онкологическими заболеваниями за ру... | Подборка наиболее крупных по размеру вложений компаний.
26 26 комментариев
3928 просмотров
Список за... | vc.ru/futu... |
11.10.2018 | Allogene Therapeutics Raises $324 Million in IPO as Shares S... | - | labusiness... |
14.09.2018 | ‘Off-the-shelf’ CAR-T company Allogene files for $100M IPO... | On Sept. 7, the company said it raised a $120 million private financing from several funds. Allogene... | medcitynew... |
07.09.2018 | Daily funding roundup - September 7th, 2018 | Scipher Medicine raised $10M led by Khosla Ventures; Allogen Therapeutics raised $120M
Pani Systems:... | vator.tv/n... |
07.09.2018 | Allogene raises $120M for ‘off-the-shelf’ CAR-T development... | The firm – of which Kite founders David Chang and Arie Belldegrun respectively serve as CEO and exec... | medcitynew... |
06.09.2018 | Allogene Therapeutics Completes a $120 Million Private Finan... | - | tworiver.c... |
- | ‘Off-the-shelf’ CAR-T company Allogene files for $100M IPO... | With the ink barely dry on its recent private financing, and only slightly drier on its initial big ... | medcitynew... |
- | New Hope for Patients as Science Advances in Allogeneic CAR ... | Five years ago, the FDA approval of autologous CAR T therapy for the treatment of certain late-stage... | statnews.c... |
- | Allogene gets FDA go-ahead to start ‘off-the-shelf’ CAR-T st... | A company founded by former executives of Kite Pharma will start a Phase I study of a so-called “off... | medcitynew... |
- | Moderna Therapeutics seeks $500M for IPO | A company developing drugs that target the messenger RNA pathway has filed for what could be the lar... | medcitynew... |
- | Astellas partners with Adaptimmune in latest move into cell ... | Although the two CAR-T cell therapies that the Food and Drug Administration approved in 2017 remain ... | medcitynew... |
- | Allogene raises $120M for ‘off-the-shelf’ CAR-T development... | A company started by former executives from Kite Pharma has raised $120 million to develop the next ... | medcitynew... |
- | Moderna raises more than $600M in biggest-ever biotech IPO | A biotechnology company that sought to pull off the largest ever initial public offering in its sect... | medcitynew... |
- | Allogene ‘off-the-shelf’ CAR-T for leukemia shows high respo... | A company developing off-the-shelf CAR-T cell therapies that went from startup phase to an initial p... | medcitynew... |
- | Life sciences VC investment trends similar to tech, but ther... | Venture capital investing has already reached a 10-year high in 2018, according to a report last wee... | medcitynew... |
- | Allogeneic CAR T products: The next frontier in cancer treat... | Innovation in the fight against cancer has come in great waves. The first came with the discovery of... | statnews.c... |
- | Beyond the myths of scientific breakthroughs | There are two great myths in science. The first is of the lone inventor, emerging from the basement ... | statnews.c... |